The COVID-19 Rapid Diagnostic Test Kit is divided into COVID-19 Rapid Diagnostic Test Kit and COVID-19 Antigen Rapid Test Kit according to the detection components.
This report contains market size and forecasts of COVID-19 Rapid Diagnostic Test Kit in global, including the following market information:
Global COVID-19 Rapid Diagnostic Test Kit Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global COVID-19 Rapid Diagnostic Test Kit Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five COVID-19 Rapid Diagnostic Test Kit companies in 2021 (%)
The global COVID-19 Rapid Diagnostic Test Kit market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Antibody Rapid Test Kit Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of COVID-19 Rapid Diagnostic Test Kit include RayBiotech Life, Aurora Biomed, SD Biosensor, INSTI, CTK Biotech, SBL Testing Technologies, Biopanda, Roche Diagnostics and JOYSBIO, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the COVID-19 Rapid Diagnostic Test Kit manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global COVID-19 Rapid Diagnostic Test Kit Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global COVID-19 Rapid Diagnostic Test Kit Market Segment Percentages, by Type, 2021 (%)
Antibody Rapid Test Kit
Antigen Rapid Test Kit
Global COVID-19 Rapid Diagnostic Test Kit Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global COVID-19 Rapid Diagnostic Test Kit Market Segment Percentages, by Application, 2021 (%)
Hospital
Company
School
Home
Others
Global COVID-19 Rapid Diagnostic Test Kit Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global COVID-19 Rapid Diagnostic Test Kit Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies COVID-19 Rapid Diagnostic Test Kit revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies COVID-19 Rapid Diagnostic Test Kit revenues share in global market, 2021 (%)
Key companies COVID-19 Rapid Diagnostic Test Kit sales in global market, 2017-2022 (Estimated), (K Units)
Key companies COVID-19 Rapid Diagnostic Test Kit sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
RayBiotech Life
Aurora Biomed
SD Biosensor
INSTI
CTK Biotech
SBL Testing Technologies
Biopanda
Roche Diagnostics
JOYSBIO
Abingdon Health
TestLine Clinical Diagnostics
Assay Genie
Nadal-test
Panodyne
Luminex
Abbott
AESKU.GROUP
ARISTA® Biotech
iHealth
Quidel
ACCESS BIO
AUISET
Biotest Biotech
Hangzhou AllTest Biotech
ACON Biotech
Lepu Medical Technology
BGI
Phase Scientific
Assure Tech
BIOHIT Healthcare (Hefei)
Artron Laboratories
Philosys
Innovation Scientific
GenBody Inc
Medriva